Reproductive Healthcare Studio focused on advancing
pioneering research, developing innovative technologies and
building startups that aim to transform reproductive health and
fertility
HERZLIYA, Israel and SALT LAKE
CITY, Utah, July 31,
2024 /PRNewswire/ -- Induction Bio, LLC (Induction),
a reproductive healthcare company, and Arieli Capital, LLC
(Arieli), a multifaceted global investment firm, today announced
that Arieli has joined as a Partner and established the
Induction Reproductive Health Studio,
IDEAS.
IDEAS is a groundbreaking venture studio transforming basic
research into commercially viable reproductive health and fertility
solutions. Leveraging decades of experience in commercialization,
investment and venture-building, IDEAS is set to become a leading
platform for advancing reproductive health and fertility.
"Most of the world is facing profound challenges in reproductive
health and fertility, which have economic, societal and
deeply personal implications. IDEAS is working with world renowned
scientists and laboratories developing cutting-edge
technologies that benefit people globally. This crucial field is
essential for ensuring sustainable economic growth and social
stability in the future, while also empowering individuals with
greater control and ownership over their reproductive health and
fertility journey" said Katelin
Roberts, Co-Founder and Partner at Induction. "Arieli
joining us as a Partner and bringing their capabilities its
instrumental in realizing our combined vision to improve
people's lives."
IDEAS combines Induction's clinical and scientific expertise
with Arieli's investment experience and track record in fostering
innovation and international business growth. The focus is on
developing and investing in early-stage ventures to commercialize
cutting-edge technologies that enhance patient outcomes. This
platform is dedicated to securing the economic and social
well-being of future generations while supporting individuals in
achieving parenthood on their own terms and timelines.
"We are proud to partner with this exceptional team dedicated to
advancing reproductive health and fertility," said Evan Renov, Co-Founder and Managing Partner at
Arieli. "The substantial field of reproductive health presents
immense business opportunities, and Arieli is dedicated to
advancing healthcare by investing in and building groundbreaking
reproductive health and fertility technologies. These advancements
have the potential to significantly improve patient outcomes and
create substantial value in the market."
IDEAS' mission is to address reproductive health and fertility
challenges through scientific excellence. By combining world-class
science with ethically driven innovation, IDEAS aims to
revolutionize reproductive health health for all. Through
cultivating partnerships with leading global universities,
hospitals and research institutescenters, and by identifying
disruptive reproductive health and fertility technologies, IDEAS
empowers scientists and clinicians with essential strategic,
financial and commercial expertise to support their growth.
IDEAS is currently collaborating with leading academics at top
research institutions and has already established four startup
companies operating in stealth mode.
About Induction Bio:
Induction Bio, LLC (Induction) combines world-class science with
ethically driven innovation to create a better future by developing
and investing in early-stage reproductive health and fertility
technologies. We are dedicated to securing the economic and social
well-being of future generations while supporting individuals in
achieving parenthood on their own terms and timeline. For more
information, please visit: https://www.inductionbio.com
About Arieli Capital:
Arieli Capital (Arieli) is a multifaceted global investment firm
that is an active investor and partner in the next generation of
technology companies. Arieli Capital continuously strives to
identify and support companies creating real impact while keeping
financial returns as the primary objective. Arieli is a recognized
global leader in innovation, creating and operating
programs across governmental, academic and corporate partnerships.
For more information, please visit: www.arielicapital.com.
Forward-Looking Statements
This release contains forward-looking information about Arieli
Capital LLC ("Arieli") which involves substantial risks and
uncertainties that could cause actual results to differ materially
from those expressed or implied by such statements. Accordingly,
any statements included in this communication are not statements of
historical facts but may be deemed to be forward-looking statements
for purposes of the safe harbor provisions under The Private
Securities Litigation Reform Act of 1995. Forward-looking
statements are, in some cases, accompanied by words such as "may,"
"should," "would," "could," "plan," "intend," "anticipate,"
"believe," "estimate," "predict," "potential," "seem," "seek,"
"continue," "future," "will," "expect," "outlook" or other similar
words, phrases or expressions and the negatives of such words,
phrases or expressions. These forward-looking statements include,
but are not limited to, statements regarding Arieli's expectations
of future events, future opportunities, global expansion and other
growth initiatives, and Arieli's investments in such initiatives.
These statements are based on various assumptions and known or
unknown risks, uncertainties and other factors, and actual results
may differ materially. Neither Arieli nor any other person assumes
responsibility for the accuracy and completeness of the
forward-looking statements. Arieli assumes no obligation to update
any forward-looking statements or information contained in this
communication except to the extent required by law.
Contact person:
Nataf Dgani, Head of Marketing
Arieli Capital LLC
+972-547573384;
nataf@arielicapital.com
info@inductionbio.com
View original
content:https://www.prnewswire.com/news-releases/arieli-capital-joins-induction-bio-as-a-partner-and-announces-the-establishment-of-the-induction-reproductive-health-studio---ideas-302211052.html
SOURCE Arieli Capital